Syneos Health
| Syneos Health, Inc.
|
|
|---|---|
 |
|
| legal form | Inc. |
| ISIN | US87166B1026 |
| founding | 1984 |
| Seat |
Morrisville , North Carolina , United States
|
| management | Alistair Macdonald ( CEO ) |
| Number of employees | 24,000 |
| sales | 4,390,000,000 US dollars |
| Branch | Services for the pharmaceutical industry |
| Website | www.syneoshealth-commercial.com |
| As of December 31, 2018 | |
Syneos Health is a global service company for the (bio) pharmaceutical and medical technology industry and the only fully integrated service provider in the field of clinical studies and the commercialization of drugs. The company based in Morrisville, North Carolina was founded in 1984; it employs more than 23,000 people worldwide and is represented in 110 countries.
As a core competence, Syneos Health supports the development and implementation of concepts for the approval and commercialization of drugs and medical products. The company has set itself the goal of accelerating the processes in the life cycle of pharmaceuticals and medical devices so that the necessary funds can be made available to patients more quickly.
In the area of commercialization of pharmaceuticals, Syneos Health covers the entire spectrum of commercialization, from medical affairs, promotion, public relations and branding to advice and training for health care professionals and can also cover the entire range of sales.
Syneos Health is listed as a publicly traded company on the New York Stock Exchange (Nasdaq: SYNH).
Individual evidence
- ↑ Syneos Health: Our Leadership , accessed April 22, 2019
- ↑ Syneos Health: SEC-Filing Form 10-K , accessed April 22, 2019
- ↑ a b Syneos Health Commercial Germany. Accessed February 26, 2019 .
- ↑ a b Our Company. April 4, 2017, accessed February 26, 2019 .
- ↑ Bloomberg: Company Overview of Syneos Health, Inc. , accessed April 22, 2019